Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis.
Noble A. et al, (2025), Clinical epigenetics, 17
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research.
Wyatt NJ. et al, (2024), EBioMedicine, 112
Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III region.
Chen J. et al, (2024), EBioMedicine, 110
Arthritis complicating inflammatory bowel disease- the future is now.
Song K. et al, (2024), The Lancet. Rheumatology, 6, e805 - e810
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.
Pierre N. et al, (2024), Gut, 73, 1965 - 1973
The circulating methylome in childhood-onset inflammatory bowel disease.
Noble A. et al, (2024), Journal of Crohn's & colitis
Prenatal cannabis exposure is associated with alterations in offspring DNA methylation at genes involved in neurodevelopment, across the life course.
Noble AJ. et al, (2024), Molecular psychiatry
Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
Ashton JJ. et al, (2024), Gastroenterology, 167, 205 - 208
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Satsangi J. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 591 - 592
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
Kapizioni C. et al, (2024), Journal of Crohn's and Colitis, 18, 790 - 800
Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
Wellens J. et al, (2024), Inflammatory bowel diseases, 30, 1036 - 1041
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Salihovic S. et al, (2024), Nature communications, 15
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS. et al, (2024), The Lancet. Rheumatology, 6, e339 - e351
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
González Cueto E. et al, (2024), Inflammatory bowel diseases, 30, 859 - 862
Challenges in IBD Research 2024: Precision Medicine.
Syed S. et al, (2024), Inflammatory bowel diseases, 30, S39 - S54
Defining gene-lifestyle interactions in inflammatory bowel disease: progress towards understanding disease pathogenesis.
Zhao J. et al, (2024), Gut, 73, 878 - 879
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 333 - 345
Considerations for peripheral blood transport and storage during large-scale multicentre metabolome research
Alexander JL. et al, (2024), Gut, 73, 379.1 - 383
Altered DNA methylation within DNMT3A, AHRR, LTA/TNF loci mediates the effect of smoking on inflammatory bowel disease
Zhang H. et al, (2024), Nature Communications, 15